Geneva, Switzerland: The first European Clinical Practice Guidelines (CPGs) for the diagnosis and management of Wilson's disease are published today by the European Association for the Study of the ...

Since the observation that injections of 2,3-dimer-captopropanol (BAL) benefit the neurologic symptoms 8 and, in 1 case, 9 may have benefited a patient in the "preneurologic" stage, it is of the ...

Wilson’s disease is a rare genetic disorder in which copper accumulates in the body. It usually affects the liver and the brain, but can also involve the kidneys, the heart and the eyes. Symptoms are ...

Wilson’s disease is an autosomal recessive disorder caused by ATP7B mutations, leading to copper accumulation in the liver, ...

Please provide your email address to receive an email when new articles are posted on . Orphalan announced FDA approval of Cuvrior for the treatment of adults with stable Wilson’s disease who are ...

Researchers report that they have conducted promising preclinical experiments on a compound that could be used to treat Wilson's disease and possibly other disorders -- including certain types of ...

LONDON--(BUSINESS WIRE)--The global Wilson’s disease drugs market 2019-2023 is expected to post a CAGR of close to 6% during the forecast period, according to the latest market research report by ...

Wilson's Disease, also known as hepatolenticular degeneration, is a genetic disease involving the inability of the body to remove excess copper. Small amounts of copper are essential for normal living ...